Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
Yi‐Tsung Lu, Melissa Plets, Gareth Morrison, Alexander Cunha, Steven Cen, Suhn K. Rhie, Kimberly D. Siegmund, Siamak Daneshmand, David I. Quinn, Joshua J. Meeks, Seth P. Lerner, Daniel P. Petrylak, David J. McConkey, Thomas W. Flaig, Ian M. Thompson, Amir Goldkorn
Topics & Concepts
MedicineBladder cancerOncologyCystectomyDNA methylationBiomarkerInternal medicineProspective cohort studyNeoadjuvant therapyPredictive markerMethylationChemotherapyCell-free fetal DNACancerGene expressionBiologyGeneBiochemistryPrenatal diagnosisPregnancyGeneticsFetusBreast cancerBladder and Urothelial Cancer TreatmentsEpigenetics and DNA MethylationCancer Genomics and Diagnostics